BioSenic S.A. (BR:BIOS) — Stock Price

€0.00 EUR
▲ 0.00% today

BioSenic S.A. (BR:BIOS) is currently trading at €0.00 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.00 and €0.00. This page tracks BioSenic S.A.'s live share price on the BR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see cash efficiency ratio of BioSenic S.A..

BioSenic S.A. (BIOS) Stock Price Chart — Daily History & Trading Volume

The chart below tracks BioSenic S.A.'s daily closing share price and trading volume on the BR exchange over the past year, giving a clear view of recent price momentum and liquidity.

BioSenic S.A. Income Statement — Revenue, Profit & Earnings by Year

BioSenic S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20232022202120202019
Total Revenue €543.00K €296.00K €312.00K €1.00 Million €0.00
Cost of Revenue €234.00K €60.00K €13.00K — €228.00K
Gross Profit €543.00K €296.00K €987.00K €1.00 Million €-228.00K
Research & Development €3.74 Million €1.03 Million €619.00K €15.27 Million €11.19 Million
SG&A €3.65 Million €619.00K €1.77 Million €1.81 Million €1.55 Million
Total Operating Expenses €7.38 Million €2.52 Million €1.18 Million €16.02 Million €11.17 Million
Operating Income €-7.04 Million €-2.32 Million €-1.19 Million €-15.02 Million €-11.17 Million
EBITDA €-6.80 Million €-2.26 Million €-864.00K €-14.83 Million €-6.69 Million
EBIT €-7.03 Million €-2.32 Million €-877.00K €-15.01 Million €-6.92 Million
Interest Expense €5.95 Million €278.00K €107.00K €747.00K €398.00K
Income Before Tax €-29.03 Million €-3.05 Million €-984.00K €-15.75 Million €-10.30 Million
Income Tax Expense €-7.00K €-1.02 Million €89.00K €78.00K €38.00K
Net Income €-28.78 Million €-2.04 Million €-984.00K €-11.94 Million €-10.46 Million

BioSenic S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes BioSenic S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €4.74 Million €9.56 Million €29.32 Million €19.77 Million €24.84 Million
Total Current Assets €1.63 Million €1.85 Million €4.63 Million €1.12 Million €18.82 Million
Cash & Equivalents — — — — —
Short-term Investments — €398.00K €-111.00K €1.20 Million —
Net Receivables €1.01 Million €334.00K €2.49 Million €2.58 Million €3.84 Million
Inventory — — — €2.22 Million —
Property, Plant & Equipment — — — €863.00K €226.00K
Goodwill — €0.00 €1.80 Million €0.00 —
Total Liabilities €31.55 Million €32.26 Million €26.20 Million €26.54 Million €21.51 Million
Total Current Liabilities €7.96 Million €15.84 Million €10.35 Million €1.49 Million €9.79 Million
Long-term Debt — €15.57 Million €14.78 Million €19.24 Million €11.67 Million
Net Debt €27.34 Million €28.40 Million €18.99 Million €11.29 Million €149.00K
Total Stockholder Equity €-25.07 Million €-22.91 Million €3.53 Million €-2.67 Million €3.33 Million
Retained Earnings €-39.59 Million €-34.89 Million €-5.72 Million €-7.22 Million €-73.08 Million

BioSenic S.A. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how BioSenic S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €-2.23 Million €-3.47 Million €-1.91 Million €-12.78 Million €-16.08 Million
Capital Expenditures €2.23 Million €3.50 Million €5.00K €207.00K €93.00K
Free Cash Flow — €-3.47 Million €-1.92 Million €-12.99 Million €-16.18 Million
Investing Cash Flow €31.00K €6.00K €1.95 Million €-204.00K €11.91 Million
Financing Cash Flow €2.48 Million €1.74 Million €1.04 Million €1.17 Million €10.19 Million
Dividends Paid — — — — —
Stock-Based Compensation — — — €-99.00K €266.00K
Depreciation €196.00K €243.00K €60.00K €186.00K €601.00K
Change in Cash €274.00K €-1.73 Million €1.09 Million €-5.14 Million €6.01 Million

BioSenic S.A. Earnings History — EPS Actual vs. Analyst Estimates

Track BioSenic S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 03, 2025 -0.02 0.00 —
May 26, 2025 — — —
Mar 04, 2025 — — —
Oct 29, 2024 — — —
Sep 29, 2024 0.00 0.00 —
May 22, 2023 0.01 — —
Oct 25, 2022 0.00 0.00 —
Sep 07, 2022 -0.15 — —